Succinimide and maleimide cytokine inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 207/404 (2006.01) A61K 31/40 (2006.01) A61K 31/44 (2006.01) C07D 207/263 (2006.01) C07D 207/448 (2006.01) C07D 209/44 (2006.01) C07D 209/48 (2006.01) C07D 209/52 (2006.01) C07D 401/06 (2006.01) C07D 403/06 (2006.01)

Patent

CA 2233975

Novel succinimides and maleimides are inhibitors or tumor necrosis factor .alpha. and phosphodiesterase and can be used to combat cachexia, endotoxic shock, retrovirus replication, asthma, and inflammatory conditions. A typical embodiment is methyl 3-(3',4',5',6'-tetrahydrophthalimido)-(3",4"-dimethoxyphenyl)propionate. The novel compounds have the following formula: (see formula I) in which: R1 is -CH2-, -CH2CO-, or -CO-; R2, R3, R4 and R5 are more fully described in the disclosure.

L'invention concerne de nouveaux succinimides et maléimides inhibiteurs du facteur de nécrose tumorale alpha et de la phosphodiestérase, que l'on peut utiliser pour traiter la cachexie, le choc endotoxique, la réplication de rétrovirus, l'asthme et les maladies inflammatoires. Dans une variante classique, il se présente sous la forme méthyle 3-(3',4',5',6'-tétrahydrophtalimido)-3-(4",4"-diméthoxyphényl)propionate.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Succinimide and maleimide cytokine inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Succinimide and maleimide cytokine inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Succinimide and maleimide cytokine inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1858650

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.